Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉

14.2K posts

Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 banner
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉

Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉

@BLLPHD

Professor @Pennmedicine We create #CellTherapy #Genetherapy - Tmunity (Kite) & Capstan (Abbvie) CoFounder, Past President @ISCTGlobal, @PNASNexus AE

Philadelphia, PA Katılım Kasım 2010
475 Takip Edilen9.7K Takipçiler
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉
🧵/1 AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy @CellPressNews AI did not “invent” a CAR T therapy here. It helped focus the search for a plausible target in a very large haystack of public single-cell and expression data. That distinction matters. The important advance is human expertise plus AI triage, followed by wet lab validation. GPNMB CAR T activity across melanoma, leukemia, and colorectal models is intriguing. The hard human enabled part is demonstrating specificity, safety, clinical translation. @PennMedicine @daniel_baker_j @JonEpsteinLab @AranyLab @carlhjune
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 tweet media
English
4
17
48
6.9K
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 retweetledi
Neil Stone
Neil Stone@DrNeilStone·
There is now no living person using an iron lung Because vaccines work ktla.com/news/last-amer…
English
121
1.1K
5.4K
53K
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉
What makes an effective public comment? A public comment is not a vote and is not politically adversarial in tone. Agencies are not supposed to finalize a rule simply because more people support or oppose it. The most effective comments become part of the rulemaking record because they offer facts, expert judgment, concrete examples, data, legal or policy concerns, and workable alternatives. The Federal Register’s rulemaking guide explains that agencies must base their final reasoning on the rulemaking record, including comments, scientific data, expert opinions, and facts; persuasive new data or policy arguments can lead an agency to change or even terminate a rulemaking. For the OMB proposed rule on federal financial assistance, comments are due July 13, 2026. OMB specifically asks commenters to identify the section of the regulation being addressed by beginning each comment with the relevant section number in brackets, such as [200.205]. Direct comment submission page: regulations.gov/commenton/OMB-…
English
0
0
0
77
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉
🚨Alarm bells for science in the USA - the administration is trying to cement political control over research funding, publication and presentation of research findings. Medical progress depends on independent expert led research and the ability to share that research with the scientific community and the public.
Matthew Herper@matthewherper

Lessons learned: OMB changes tactics in control of science statnews.com/2026/07/08/tru…

English
1
0
5
1.7K
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉 retweetledi
Reads with Ravi
Reads with Ravi@readswithravi·
This book is hilarious and on point. Instead of cliché positivity affirmations, it is a collection of sarcastic and realistic affirmations. Here are 10 of my favorites:
Reads with Ravi tweet media
English
49
221
1.4K
156.9K
Brad Loncar
Brad Loncar@bradloncar·
As NIH Director for over six years, Dr. Zerhouni is the perfect speaker to share thoughts on the critical role government plays in investing in science, and explaining the importance of it to the American public.
BiotechTV@BiotechTV

𝐒𝐩𝐞𝐚𝐤𝐞𝐫 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐦𝐞𝐧𝐭: We are excited to announce that former @NIH Director Elias Zerhouni will be speaking at our July 21st Science Summit in Kendall Square. Apply to join us: biotechtv.com/us-science-sum…

English
2
3
30
8.6K
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉
🚨👇Clinical fellows interested in cell and gene therapy applications #celltherapy #genetherapy #immunotherapy #cancer #autoimmune #hemoglobinopathies
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉@BLLPHD

Clinical CGT Applications Program for Fellows from @ISCTglobal Oct 26–27, 2026 at Penn Medicine Forty fellows. Two days. One community that lasts a career. A fully funded clinical immersion for fellows who will be selecting, prescribing, and operationalizing cell and gene therapies in hematology/oncology, transplantation, and immune-mediated diseases. Applications due July 31. Know a fellow who belongs in this room? isctglobal.org/workforce-deve…

English
0
2
6
1.7K